New Marketplace

Survey Snapshot: Seeing Progress in Transparency, but the Quest for Value Continues

Insights Report · July 19, 2018

Transparency of health care data has become widely accepted over the last few years, says Steven A. Spaulding, CLU, CHC, PAHM, Executive Vice President and Chief Health Management Officer for Arkansas BlueCross BlueShield. And he sees trust developing between payers and providers in sharing performance data.

“Maybe 5 years ago, providers would have fought tooth and nail to have that information not be made accessible to others, because at that point they felt it was being used as a weapon by health plans against providers,” he says. But today, “there’s a general understanding that the information has gotten better, and incentive programs have arisen that help providers understand the need for transparency.”

Transparency Initiatives Are Maturing But Have Far to Go

From the New Marketplace Insights Report: A Slow Path to Transparency for Patients. Click To Enlarge.

In a recent NEJM Catalyst Insights Report on transparency, only 5% of Insights Council respondents consider the concept of patient-facing transparency to be very mature at their organizations; another 33% admit that it is not mature at all.

So, despite the improvements, respondents recognize that transparency efforts are a relatively recent development and that there is room for improvement.

“I am more focused on provider-facing transparency than I am on patient-facing transparency,” Spaulding says. “I have long thought there is limited value to transparency from the patient-facing side simply because a lot of the decisions that a patient should have the ability to participate in are at the very low-acuity levels of the system, and when you get to more sophisticated problems, it’s very difficult for a patient — other than just to look for general quality ratings or general directional cost ratings — to participate in the care plan itself. It doesn’t surprise me that there’s not a lot of patient-facing transparency because it doesn’t represent value in a lot of situations.”

The impact of transparency on elements of value also points to areas for improvement, especially aspects related to cost. Just 31% of survey respondents expect that transparency alone can have a strong impact on lowering costs — notably lower than the 52% who say transparency will have a strong impact on improving quality.

Transparency Can Improve Both Quality and Cost of Care

From the New Marketplace Insights Report: A Slow Path to Transparency for Patients. Click To Enlarge.

Nancy Girard, DO, is a rural solo primary care practitioner in Alexandria Bay, New York, a Health Professional Shortage Area at the Canadian border. Many of her patients have chronic conditions that require long-term management with prescription drugs.

“One of my greatest problems with transparency has to do with prescribing medications, and not having a clue what drugs the insurance company is going to cover when I’m trying to get my patient’s medication in order.”

Even if a drug is part of the payer’s formulary, the out-of-pocket cost for the patient can spike unexpectedly. Girard sees cases where the drug is no longer covered.

“That is not very transparent. The pharmacy tells the patient all they have to do is get the doctor to do an authorization. You can spend an hour trying to get the patient their drug, or finding an equivalent — then in 6 months, it changes again,” she says.

“I talk to my patients about everything that I am doing with them. I spend a lot of time with patients, and that is a function of being in a small town,” Girard says as she describes her commitment to being transparent. “You need to be able to confidently tell a patient what a price of something is going to be.”

Mike Noonan, DO, practices family medicine at Salud Family Health Center, a Federally Qualified Health Center in Commerce City, Colorado, an industrial suburb of Denver. He, too, cites the importance of cost-related transparency for patients, but says some aspects of transparency are not needed.

“I think there are parts of transparency that are very important, for example, the costs that patients will incur for various treatments. But I think that some of the inner workings of health care are irrelevant to patients,” he says. “I feel we have a strong duty to society, and sometimes that is to protect people from themselves. Does a person need to know I feel that they have addiction risk factors, and that’s why I won’t prescribe them hydrocodone? I don’t believe so. What I believe they need to know is that this medicine is not safe and appropriate for most people.”

Noonan also addresses the importance of transparency to impact cost. “We waste money like it’s just tissue paper to throw into the fire. I understand from the point of view of policymakers and the patient’s point of view that an annual CBC [blood test] ordered for screening is insane. We say that as physicians, but we order it all the time. That’s the transparency that is important: that I’m doing this for no reason.”

Randal S. Weber, MD, is Chief Patient Experience Officer at UT MD Anderson Cancer Center in Houston. He describes the organization’s concept of the value proposition as not just outcomes divided by costs, but as the outcome achieved from care, plus the patient experience and the provider experience, divided by the cost of care.

Eventually, those clinical outcomes should be reported and transparent at the provider level, he says.

“For me, as a head and neck surgeon, it would be things like mortality rate, readmissions, return to the operating room,” Weber says. But, he cautions, “These also have to be risk-adjusted. I may see a different cohort of patients than you do. My patients may be sicker, have a more advanced disease stage. It is tricky when you get to that level of reporting.”

Despite the challenges and caveats, the multipronged transparency effort is essential. “The ultimate upside [of transparency] is to improve the patient experience globally, but it’s also reporting on quality and safety and cost of care. That really feeds right in to the value proposition,” Weber says. “The federal government has already implemented compensation based on outcomes and value. Insurers and payers of insurance premiums in the not-too-distant future will look at these data and channel patients to institutions and providers of the best outcomes and patient experience as part of that decision-making process on where to allocate your dollars to pay for health care.”

Call for submissions:

Now inviting expert articles, longform articles, and case studies for peer review

Connect

A weekly email newsletter featuring the latest actionable ideas and practical innovations from NEJM Catalyst.

Learn More »

More From New Marketplace
Value-Based Pricing Would Lower Drug Costs and Boost Quality

New Marketplace Buzz Survey: Who’s to Blame for Drug Pricing, and How to Fix It

This survey of NEJM Catalyst Insights Council members shows strong opinions about the impact of high prices, who’s to blame, and how to fix the problem.

A Look at the Four Pillars of Primary Care

Pay for Relationship: A Novel Solution to the Primary Care Crisis

What society should and can pay for is care that enables relationships between patients and providers.

Examples of Stages of AI Technology Development and Diffusion

How Artificial Intelligence Is Changing Health Care Delivery

The development of intelligent machines holds great promise for making health care delivery more accurate, efficient, and accessible, but challenges remain for incorporating AI technology into clinical and administrative settings.

Recommendations to Resolve Information Asymmetry at the Strategic Level

Information Asymmetry: The Untapped Value of the Patient

The knowledge and preferences that patients could — and should — share with clinicians would restore balance to point-of-care interactions, leading to better outcomes and enhanced value.

Key Components for Health Care Systems to Address Patient Affordability

The Next Frontier in Reducing Costs of Care: Patient Affordability

To create meaningful point-of-care guidance so that patients can make informed medical and financial decisions, health system leaders and policymakers can develop interventions to address four major components of a proposed patient affordability scale.

Direct-to-Consumer Telemedicine Is the Biggest Coming Threat to Traditional Health Care Organizations

Survey Snapshot: Mega-Mergers and Telemedicine Accelerate Convenient Care Growth

NEJM Catalyst Insights Council members detail how providers are looking to direct-to-consumer telemedicine and partnerships to meet the differing needs of their patient populations.

Opelka01_pullquote - ACS IPU team-based surgical care bundles playbook

Developing a Playbook for IPU-based Surgical Care and New Payment Models

The complexity associated with most surgery lends itself to the integrated practice unit structure, with its focus on the care team and value-based payment.

Convenient Care Has Been Good Overall for the Health Care Industry

New Marketplace Survey: Convenient Care — Opportunity, Threat, or Both?

A survey of the NEJM Catalyst Insights Council shows conflicting views about both the value of convenient care and what respondents’ organizations should do.

Payer-Provider Partnerships Produce Better Quality Outcomes 3 - community health plan - physician partnership

New Research Shows How Payer-Provider Partnerships Can Accelerate Adoption of Evidence-Based Care

Five best practices that are replicable and scalable are facilitating improved clinical and financial outcomes today.

30-Day Mortality Rates at Non-Teaching and Major Teaching Hospitals 2013-2014 - value-based care at academic medical centers

What Value-Based Payment Means for Academic Medical Centers

Academic medical centers must become as dedicated to advancing operational and clinical efficiency as they have been to advancing the science of medicine.

Connect

A weekly email newsletter featuring the latest actionable ideas and practical innovations from NEJM Catalyst.

Learn More »

Topics

Value Based Care

222 Articles

New Marketplace Buzz Survey: Who’s to…

This survey of NEJM Catalyst Insights Council members shows strong opinions about the impact of…

From the Commonwealth to Obamacare: Reflections…

The former Executive Director of the Commonwealth Health Insurance Connector — a model for the…

Medicare and Medicaid

131 Articles

From the Commonwealth to Obamacare: Reflections…

The former Executive Director of the Commonwealth Health Insurance Connector — a model for the…

Insights Council

Have a voice. Join other health care leaders effecting change, shaping tomorrow.

Apply Now